Search

everythinglearnresearchcommunity

for

Search:↓

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Kremen is crucial for proper development and preventing tumors by regulating Wnt signaling.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Mutations in the AP1B1 gene cause a new syndrome with skin, hearing, and developmental issues.

Lack of KSR1 stops certain skin tumors in mice.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Fluphenazine and iloprost can induce hair growth.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Lack of TG2 increases fat storage and lowers cell cleanup in skin oil cells.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Cells in hair follicles help create fat cells in the skin by releasing a protein called Sonic Hedgehog.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

mEphA1 receptor tyrosine kinase is important for skin and hair development and may play a role in certain diseases.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Hair growth and development are controlled by specific signaling pathways.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

TRPS1 is crucial for bone, kidney, and hair follicle development.